Captopril renal scintigraphy in renovascular hypertension.
Renovascular disease is a common cause of secondary hypertension. Renal artery stenosis is present in up to one third of patients with clinical markers suggestive of renovascular hypertension, such as hypertension refractory to medical management, severe hypertension in a young patient and worsening of renal function after the use of an angiotensin-converting enzyme inhibitor. Early discovery of renal artery stenosis may allow amelioration or cure of the hypertension and halt progressive loss of renal function. Although renal arteriography remains the gold-standard aid to diagnosis and to planning surgical intervention, it is an invasive procedure that may cause deterioration of renal function. In the presence of renal artery stenosis, glomerular filtration is maintained by angiotensin. Administration of captopril in renal scintigraphy removes this compensatory mechanism and causes a temporary impairment of renal function in the affected kidney. Nuclear tracers can visualize this impairment, thus allowing assessment of the physiologic significance of a renal artery stenosis. The test can be done as a outpatient procedure.
Khairullah
Q T
QT
University of Iowa Hospitals and Clinics, Iowa City, USA.
Somers
D L
DL
Aktay
R
R
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril; D003937:Diagnosis, Differential; D006801:Humans; D006978:Hypertension, Renovascular / Q000175:diagnosis / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril